Cost-effectiveness analysis of remote glycemic monitoring in patients with diabetes mellitus in the Russian Federation
Medical Technologies. Assessment and Choice · 17.03.2026 · 48 (1) · 92
DOI: 10.17116/medtech20264801192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Technologies. Assessment and Choice, erschienen am 17.03.2026. Verfasst von V.A. Ryagina und 7 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
To evaluate clinical and economic effectiveness of remote glycemic monitoring (RGM) in patients with type 1 and type 2 diabetes mellitus (DM) receiving non-insulin therapy in the Russian Federation. Material and methods. Cost-effectiveness analysis implied comparison of RGM with routine monitoring of adults with DM. Direct medical costs for treating DM and its complications were estimated in Markov model. Life-years saved was used as effectiveness criterion. The incremental cost-effectiveness ratio (ICER) was calculated in rubles per year of life saved for RGM compared with routine monitoring. ICER was compared with willingness-to-pay threshold equal to three times the per capita gross domestic product for 2024. The modeling time horizon was 5 years.
Results
ICER for DM relative to routine practice was RUB 3.135.234.88 per life-year gained in patients with type 2 diabetes receiving non-insulin therapy, and RUB 3.146.031.73 per life-year gained in patients with type 1 diabetes that is below willingness-to-pay threshold (RUB 4.129.433.70).
Conclusion
Cost-effectiveness analysis demonstrates clinical and economic effectiveness of RGM in patients with type 1 and type 2 diabetes receiving non-insulin therapy over a 5-year period.
Zitieren
APA
Ryagina, V., Sukhorukikh, O., Solyanik, E., Ibragimova, L., Fedyaev, D., Zheleznyakova, I., Omelyanovskiy, V., & Mokrysheva, N. (2026). Cost-effectiveness analysis of remote glycemic monitoring in patients with diabetes mellitus in the Russian Federation. Medical Technologies. Assessment and Choice, 48(1), 92. https://doi.org/10.17116/medtech20264801192
Vancouver
Ryagina V, Sukhorukikh O, Solyanik E, Ibragimova L, Fedyaev D, Zheleznyakova I, et al. Cost-effectiveness analysis of remote glycemic monitoring in patients with diabetes mellitus in the Russian Federation. Medical Technologies. Assessment and Choice. 2026;48(1):92. doi:10.17116/medtech20264801192
BibTeX
@article{Ryagina2026,
author = {Ryagina, V.A. and Sukhorukikh, O.A. and Solyanik, E.A. and Ibragimova, L.I. and Fedyaev, D.V. and Zheleznyakova, I.A. and Omelyanovskiy, V.V. and Mokrysheva, N.G.},
title = {Cost-effectiveness analysis of remote glycemic monitoring in patients with diabetes mellitus in the Russian Federation},
journal = {Medical Technologies. Assessment and Choice},
year = {2026},
volume = {48},
number = {1},
pages = {92},
doi = {10.17116/medtech20264801192}
}
EUVIMED